These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 17185442)

  • 21. Febrile neutropenia in paediatric peripheral blood stem cell transplantation, in -vitro sensitivity data and clinical response to empirical antibiotic therapy.
    Ansari SH; Nasim S; Ahmed A; Irfan M; Ishaque A; Farzana T; Panjwani VK; Taj M; Shamsi TS
    J Coll Physicians Surg Pak; 2006 Nov; 16(11):704-8. PubMed ID: 17052420
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cefepime monotherapy for treatment of febrile neutropenia in children.
    Ariffin H; Ai CL; Lee CL; Abdullah WA
    J Paediatr Child Health; 2006 Dec; 42(12):781-4. PubMed ID: 17096713
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oral antibiotics for febrile patients with neutropenia due to cancer chemotherapy.
    Rubenstein EB; Rolston KV; Kim YJ
    N Engl J Med; 2000 Jan; 342(1):56; author reply 56-8. PubMed ID: 10627211
    [No Abstract]   [Full Text] [Related]  

  • 24. Empirical antimicrobial treatment for chemotherapy-induced febrile neutropenia.
    Bal AM; Gould IM
    Int J Antimicrob Agents; 2007 May; 29(5):501-9. PubMed ID: 17346939
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prospective audit of treatment of paediatric febrile neutropenia in Australasia.
    Chamberlain JD; Smibert E; Skeen J; Alvaro F
    J Paediatr Child Health; 2005 Nov; 41(11):598-603. PubMed ID: 16398846
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Persistent fever in patients with neutropenia.
    Corey L; Boeckh M
    N Engl J Med; 2002 Jan; 346(4):222-4. PubMed ID: 11807145
    [No Abstract]   [Full Text] [Related]  

  • 27. Piperacillin-tazobactam monotherapy in high-risk febrile and neutropenic cancer patients.
    Viscoli C; Cometta A; Kern WV; Bock R; Paesmans M; Crokaert F; Glauser MP; Calandra T;
    Clin Microbiol Infect; 2006 Mar; 12(3):212-6. PubMed ID: 16451406
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Outpatient treatment of fever and neutropenia for low risk pediatric cancer patients.
    Mullen CA; Petropoulos D; Roberts WM; Rytting M; Zipf T; Chan KW; Culbert SJ; Danielson M; Jeha SS; Kuttesch JF; Rolston KV
    Cancer; 1999 Jul; 86(1):126-34. PubMed ID: 10391572
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low risk episodes of fever and neutropenia in pediatric oncology: Is outpatient oral antibiotic therapy the new gold standard of care?
    Ammann RA; Simon A; de Bont ES
    Pediatr Blood Cancer; 2005 Sep; 45(3):244-7. PubMed ID: 15747334
    [No Abstract]   [Full Text] [Related]  

  • 30. Fever and neutropenia during intensive chemotherapy.
    Klastersky J
    Ann Oncol; 1993 Aug; 4(7):603-6. PubMed ID: 8363991
    [No Abstract]   [Full Text] [Related]  

  • 31. First-day step-down to oral outpatient treatment versus continued standard treatment in children with cancer and low-risk fever in neutropenia. A randomized controlled trial within the multicenter SPOG 2003 FN study.
    Brack E; Bodmer N; Simon A; Leibundgut K; Kühne T; Niggli FK; Ammann RA
    Pediatr Blood Cancer; 2012 Sep; 59(3):423-30. PubMed ID: 22271702
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical guide for the evaluation and treatment of patients with neutropenia and fever].
    García-Rodríguez JA; Gobernado M; Gomis M; Mensa J; Picazo J; Prieto J; Carreras E; R De La Cámara R; Sanz MA; ;
    Rev Esp Quimioter; 2001 Mar; 14(1):75-83. PubMed ID: 11376354
    [No Abstract]   [Full Text] [Related]  

  • 33. [Chemotherapy-induced febrile neutropenia: about 200 episodes. Clinical, microbiological and therapeutic characteristics].
    Gharbi O; Ben Hadj Hassen S; Kaabia N; Limam S; Hadj Amor M; Ben Fatma L; Landolsi A; Hochlef M; Letaief A; Boukadida J; Ben Ahmed S
    Pathol Biol (Paris); 2008 May; 56(3):154-7. PubMed ID: 18178025
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Meropenem plus amikacin versus piperacillin-tazobactam plus netilmicin as empiric therapy for high-risk febrile neutropenia in children.
    Aksoylar S; Cetingül N; Kantar M; Karapinar D; Kavakli K; Kansoy S
    Pediatr Hematol Oncol; 2004 Mar; 21(2):115-23. PubMed ID: 15160510
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The feasibility of early discharge with oral antimicrobial therapy in low risk patients with febrile neutropenia following chemotherapy for hematologic malignancies.
    Cordonnier C
    Haematologica; 2006 Feb; 91(2):150a. PubMed ID: 16461296
    [No Abstract]   [Full Text] [Related]  

  • 36. Oral antibiotics for febrile patients with neutropenia due to cancer chemotherapy.
    Lishner M
    N Engl J Med; 2000 Jan; 342(1):55-6; author reply 56-8. PubMed ID: 10627210
    [No Abstract]   [Full Text] [Related]  

  • 37. Identifying risk factors for refractory febrile neutropenia in patients with lung cancer.
    Fujita M; Tokunaga S; Ikegame S; Harada E; Matsumoto T; Uchino J; Watanabe K; Nakanishi Y
    J Infect Chemother; 2012 Feb; 18(1):53-8. PubMed ID: 21773751
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Successful treatment with Protein C of febrile neutropenia in pediatric patients during cancer therapy.
    Giordano P; Cecinati V; Delvecchio GC; Arcamone G; De Leonardis F; Grassi M; Brescia LP; Santoro N; De Mattia D
    Immunopharmacol Immunotoxicol; 2009 Jun; 31(2):293-8. PubMed ID: 19235536
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oral antibiotics for febrile patients with neutropenia due to cancer chemotherapy.
    Sezer O
    N Engl J Med; 2000 Jan; 342(1):56; author reply 56-8. PubMed ID: 10627212
    [No Abstract]   [Full Text] [Related]  

  • 40. Treatment of febrile neutropenic patients with cancer who require hospitalization: a prospective randomized study comparing imipenem and cefepime.
    Raad II; Escalante C; Hachem RY; Hanna HA; Husni R; Afif C; Boktour MR; Whimbey EE; Kontoyiannis D; Jacobson K; Kantarjian H; Levett LM; Rolston KV
    Cancer; 2003 Sep; 98(5):1039-47. PubMed ID: 12942573
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.